Aaron S. Rapaport, Ph.D.
Affiliations: | 2014 | Biology & Biomedical Sciences (Immunology) | Washington University, Saint Louis, St. Louis, MO |
Area:
Immunology, Virology BiologyGoogle:
"Aaron Rapaport"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Marco Colonna | grad student | 2014 | Washington University | |
| (In Vivo Functions of Inhibitory Immunoreceptors During Viral Infection.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Galsky MD, Guan X, Rishipathak D, et al. (2024) Immunomodulatory effects and improved outcomes with cisplatin- versus carboplatin-based chemotherapy plus atezolizumab in urothelial cancer. Cell Reports. Medicine. 101393 |
| Zhang L, Li Z, Skrzypczynska KM, et al. (2020) Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer. Cell. 181: 442-459.e29 |
| Yu X, Zhang L, Chaudhry A, et al. (2020) Unravelling the heterogeneity and dynamic relationships of tumor-infiltrating T cells by single-cell RNA sequencing analysis. Journal of Leukocyte Biology |
| Rapaport AS, Schriewer J, Gilfillan S, et al. (2015) The Inhibitory Receptor NKG2A Sustains Virus-Specific CD8(+) T Cells in Response to a Lethal Poxvirus Infection. Immunity |
| KC W, Satpathy AT, Rapaport AS, et al. (2014) L-Myc expression by dendritic cells is required for optimal T-cell priming. Nature. 507: 243-7 |
| Albring JC, Sandau MM, Rapaport AS, et al. (2010) Targeting of B and T lymphocyte associated (BTLA) prevents graft-versus-host disease without global immunosuppression. The Journal of Experimental Medicine. 207: 2551-9 |
| Gilfillan S, Chan CJ, Cella M, et al. (2008) DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors. The Journal of Experimental Medicine. 205: 2965-73 |